DK1351676T3 - Anvendelse af isovaleryl-L-carnitin til fremstilling af et lægemiddel til forebyggelse og behandling af frakturer - Google Patents

Anvendelse af isovaleryl-L-carnitin til fremstilling af et lægemiddel til forebyggelse og behandling af frakturer

Info

Publication number
DK1351676T3
DK1351676T3 DK01271219T DK01271219T DK1351676T3 DK 1351676 T3 DK1351676 T3 DK 1351676T3 DK 01271219 T DK01271219 T DK 01271219T DK 01271219 T DK01271219 T DK 01271219T DK 1351676 T3 DK1351676 T3 DK 1351676T3
Authority
DK
Denmark
Prior art keywords
isovaleryl
carnitine
fractures
drug
prevention
Prior art date
Application number
DK01271219T
Other languages
Danish (da)
English (en)
Inventor
Aleardo Sigma-Tau Ind Koverech
Alberta Zallone
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1351676T3 publication Critical patent/DK1351676T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK01271219T 2000-12-21 2001-12-04 Anvendelse af isovaleryl-L-carnitin til fremstilling af et lægemiddel til forebyggelse og behandling af frakturer DK1351676T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000688A IT1317079B1 (it) 2000-12-21 2000-12-21 Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
PCT/IT2001/000614 WO2002049639A1 (en) 2000-12-21 2001-12-04 Use of isovaleryl l-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis

Publications (1)

Publication Number Publication Date
DK1351676T3 true DK1351676T3 (da) 2005-12-19

Family

ID=11455074

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01271219T DK1351676T3 (da) 2000-12-21 2001-12-04 Anvendelse af isovaleryl-L-carnitin til fremstilling af et lægemiddel til forebyggelse og behandling af frakturer

Country Status (15)

Country Link
US (2) US6906102B2 (sk)
EP (1) EP1351676B1 (sk)
AT (1) ATE301998T1 (sk)
AU (1) AU2002217431A1 (sk)
CA (1) CA2434962C (sk)
CZ (1) CZ304356B6 (sk)
DE (1) DE60112802T2 (sk)
DK (1) DK1351676T3 (sk)
ES (1) ES2247005T3 (sk)
HU (1) HU227342B1 (sk)
IT (1) IT1317079B1 (sk)
MX (1) MXPA03006332A (sk)
PL (1) PL207879B1 (sk)
SK (1) SK287306B6 (sk)
WO (1) WO2002049639A1 (sk)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
IT1291141B1 (it) * 1997-04-16 1998-12-29 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente una alcanoil l-carnitina, atta a stimolare la moltiplicazione e la crescita degli osteoblasti
IT1299191B1 (it) 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa

Also Published As

Publication number Publication date
DE60112802D1 (de) 2005-09-22
HUP0400735A3 (en) 2009-01-28
US20050143458A1 (en) 2005-06-30
CZ20031890A3 (cs) 2004-04-14
US7084174B2 (en) 2006-08-01
ES2247005T3 (es) 2006-03-01
HUP0400735A2 (hu) 2004-07-28
ITRM20000688A1 (it) 2002-06-21
WO2002049639A1 (en) 2002-06-27
CA2434962C (en) 2010-02-09
SK287306B6 (sk) 2010-06-07
PL367293A1 (en) 2005-02-21
ATE301998T1 (de) 2005-09-15
EP1351676B1 (en) 2005-08-17
IT1317079B1 (it) 2003-05-26
SK8912003A3 (en) 2003-11-04
PL207879B1 (pl) 2011-02-28
EP1351676A1 (en) 2003-10-15
MXPA03006332A (es) 2004-04-21
AU2002217431A1 (en) 2002-07-01
ITRM20000688A0 (it) 2000-12-21
CA2434962A1 (en) 2002-06-27
CZ304356B6 (cs) 2014-03-26
US6906102B2 (en) 2005-06-14
DE60112802T2 (de) 2006-03-16
US20040077718A1 (en) 2004-04-22
HU227342B1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
BR9710536A (pt) Isobutilgaba e seus derivados para o tratamento da dor
DE602004005814D1 (de) Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
HK1068606A1 (en) Novel aminobenzoephenones
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
DE60216970D1 (de) Implantierbare herzstimulationsvorrichtung sowie diese vorrichtung enthaltendes system
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
GB0020504D0 (en) Therapeutic method
HUP0401913A2 (hu) Bromhidrosis kezelésére és megelőzésére szolgáló gyógyszerkészítmény
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
DK1351676T3 (da) Anvendelse af isovaleryl-L-carnitin til fremstilling af et lægemiddel til forebyggelse og behandling af frakturer
DE60203878D1 (de) Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen
NZ527655A (en) Combination of a taxane (docetaxel) and a cyclin-dependent kinase inhibitor (flavopiridol)
SE0101256D0 (sv) Treatment of low back pain
DE60319241D1 (de) Analoga zur behandlung von thalassämie
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
AU2003281257A8 (en) A novel use of rapamycin and structural analogues thereof
SE0101258D0 (sv) Treatment of low back pain and whiplash associated disorder
DE60315666D1 (de) Furopyridin- und furopyrimidinderivate zur behandlung von hyperproliferativen erkrankungen
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
RU2002105074A (ru) Способ лечения и профилактики развития гипертрофических и келоидных рубцов
DE10390700D2 (de) Kapsel zur zeitversetzten Verabreichung von Nähr- und/oder Wirkstoffen
NO20043774L (no) The use of devazenide as analgesic agent